Abstract
Breast cancer is a major global health concern, appealing for precise prognostic approaches. Thus, the need is to have studies focusing on the identification and recognition of preliminary events leading to the disease. The present study reports the tracing of precancerous progression and serum proteomic analysis in a breast cancer model developed as a result of 7,12-dimethylbenz[a]anthracene (DMBA) administration. Mammary gland histological changes of prime importance were examined by histopathology, and immunohistochemical analysis with Ki-67 was performed to monitor enhanced cell proliferation, right from the onset of hyperplasia till neoplasia. Serum proteomics (one-dimensional (1D) and two-dimensional (2D) electrophoresis, followed by MALDI-TOF MS characterization) was performed to decipher the differentially expressed serum proteins in animals undergoing tumorigenesis vis-à-vis controls. The significance of our study lies in reporting the significantly reduced expression of two proteins: histone–lysine N-methyltransferase (SETD2) and sorting nexin-9 (SNX9) at very early stage (13 weeks) of tumorigenesis, while the full-fledged tumors developed after 6 months. The reduced expression of SETD2 and SNX9 was validated by western blotting and relative expression analysis using quantitative real-time PCR. These proteins may hence prove as potentially useful tools in search for prognostic markers for the early detection of mammary cancer.
Similar content being viewed by others
References
Adrian G, Alecsandru B, Miclaus V, Bouari C, Taulescu M, Pompei B, et al. (2011) Comparative aspects regarding MNU-induced mammary carcinogenesis in immature Sprague-Dowley and Whistar rats. Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca Veterinary Medicine. 1
Al Sarakbi W, Sasi W, Jiang WG, Roberts T, Newbold RF, Mokbel K (2009) The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters. BMC Cancer 9:290
Al-Dhaheri WS, Hassouna I, Al-Salam S, Karam SM (2008) Characterization of breast cancer progression in the rat. Ann N Y Acad Sci 1138:121–131
Alegre MM, Robison RA, O’Neill KL (2012) Thymidine kinase 1 upregulation is an early event in breast tumor formation. J Oncol. doi:10.1155/2012/575647
Almendinger J, Doukoumetzidis K, Kinchen JM, Kaech A, Ravichandran KS, Hengartner MO (2011) A conserved role for SNX9-family members in the regulation of phagosome maturation during engulfment of apoptotic cells. PLoS One 6:e18325
Ariazi JL, Haag JD, Lindstrom MJ, Gould MN (2005) Mammary glands of sexually immature rats are more susceptible than those of mature rats to the carcinogenic, lethal, and mutagenic effects of N-nitroso-N-methylurea. Mol Carcinog 43:155–164
Ashrafi M, Bathaie SZ, Abroun S (2012) High expression of cyclin D1 and p21 in N-nitroso-N-methylurea-induced breast cancer in Wistar albino female rats. Cell Journal 14:193–202
Banin Hirata BK, Oda JM, Losi Guembarovski R, Ariza CB, de Oliveira CE, Watanabe MA (2014) Molecular markers for breast cancer: prediction on tumor behavior. Dis Markers 2014:513158
Beckmann MW, Niederacher D, Schnurch HG, Gusterson BA, HG B (1997) Multistep carcinogenesis of breast cancer and tumour heterogeneity. J Mol Med (Berl) 75:429–439
Bendris N, Stearns CJ, Reis CR, Rodriguez-Canales J, Liu H, Witkiewicz AW et al (2016a) Sorting nexin 9 negatively regulates invadopodia formation and function in cancer cells. J Cell Sci 129:2804–2816
Bendris N, Williams KC, Reis CR, Welf ES, Chen PH, Lemmers B, et al. (2016b) SNX9 promotes metastasis by enhancing cancer cell invasion via differential regulation of RhoGTPases. Mol Biol Cell
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Brauer HA, D'Arcy M, Libby TE, Thompson HJ, Yasui YY, Hamajima N et al (2014) Dermcidin expression is associated with disease progression and survival among breast cancer patients. Breast Cancer Res Treat 144:299–306
Choi J, Psarommatis B, Gao YR, Zheng Y, Handelsman DJ, Simanainen U (2014) The role of androgens in experimental rodent mammary carcinogenesis. Breast Cancer Res 16:483
Dhillon PK (2009) Breast cancer factsheet. Mortality 11:10–18
Dias M, Cabrita S, Sousa E, França B, Patrício J, Oliveira C (1999) Benign and malignant mammary tumors induced by DMBA in female Wistar rats. Eur J Gynaecol Oncol 20:285–288
Ding L, Zhao Y, Warren CL, Sullivan R, Eliceiri KW, Shull JD (2013) Association of cellular and molecular responses in the rat mammary gland to 17beta-estradiol with susceptibility to mammary cancer. BMC Cancer 13:573
Duffy M (2007) Serum markers in breast cancer: are they of value and will they get better? Ned Tijdschr Klin Chem Labgeneesk 32:93
Duns G, van den Berg E, van Duivenbode I, Osinga J, Hollema H, Hofstra RM et al (2010) Histone methyltransferase gene SETD2 is a novel tumor suppressor gene in clear cell renal cell carcinoma. Cancer Res 70:4287–4291
Edmunds JW, Mahadevan LC, Clayton AL (2008) Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation. EMBO J 27:406–420
Ermiah E, Buhmeida A, Abdalla F, Khaled BR, Salem N, Pyrhonen S et al (2012) Prognostic value of proliferation markers: immunohistochemical ki-67 expression and cytometric s-phase fraction of women with breast cancer in Libya. J Cancer 3:421–431
Feng M, Feng C, Yu Z, Fu Q, Ma Z, Wang F et al (2015) Histopathological alterations during breast carcinogenesis in a rat model induced by 7,12-dimethylbenz (a) anthracene and estrogen-progestogen combinations. Int J Clin Exp Med 8:346–357
Ferrini R, Mannino E, Ramsdell E, Hill L (1996) Screening mammography for breast cancer: American College of Preventive Medicine practice policy statement. Am J Prev Med 12:340–341
Golbabapour S, Pang WW, George J, Pasupati T, Abdul-Rahman PS, Hashim OH (2011) Chemically induced breast tumors in rats are detectable in early stages by contrast enhanced magnetic resonance imaging but not by changes in the acute-phase reactants in serum. Int J Mol Sci 12:1030–1040
Inwald EC, Klinkhammer-Schalke M, Hofstadter F, Zeman F, Koller M, Gerstenhauer M et al (2013) Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Res Treat 139:539–552
Ish-Shalom E, Meirow Y, Sade-Feldman M, Kanterman J, Wang L, Mizrahi O et al (2016) Impaired SNX9 expression in immune cells during chronic inflammation: prognostic and diagnostic implications. J Immunol 196:156–167
Kanu N, Gronroos E, Martinez P, Burrell RA, Yi Goh X, Bartkova J et al (2015) SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair. Oncogene 34:5699–5708
Kill IR (1996) Localisation of the Ki-67 antigen within the nucleolus. Evidence for a fibrillarin-deficient region of the dense fibrillar component. J Cell Sci 109(Pt 6):1253–1263
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
Lei L, Wang XJ, Zheng ZG, Huang J, Cao WM, Chen ZH et al (2011) Identification of serum protein markers for breast cancer relapse with SELDI-TOF MS. Anatomical Record 294:941–944
Liu S-L, Cheng C-C, Chang C-C, Mai F-D, Wang C-C, Lee S-C et al (2011) Discovery of serum biomarkers of alcoholic fatty liver in a rodent model: C-reactive protein. J Biomed Sci 18:1–10
Lord SJ, Lei W, Craft P, Cawson JN, Morris I, Walleser S et al (2007) A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer 43:1905–1917
Luna LG (1968) Manual of histologic staining methods of the Armed Forces Institute of Pathology, 3rd edn. Blakiston Division, McGraw-Hill, New York
Lundmark R, Carlsson SR (2009) SNX9—a prelude to vesicle release. J Cell Sci 122:5–11
Menon R, Bartley J, Som S, Banerjee MR (1987) Metabolism of 7,12-dimethylbenz[a]anthracene by mouse mammary cells in serum-free organ culture medium. Eur J Cancer Clin Oncol 23:395–400
Newbold RF, Mokbel K (2010) Evidence for a tumour suppressor function of SETD2 in human breast cancer: a new hypothesis. Anticancer Res 30:3309–3311
Papaconstantinou AD, Shanmugam I, Shan L, Schroeder IS, Qiu C, Yu M et al (2006) Gene expression profiling in the mammary gland of rats treated with 7,12-dimethylbenz[a]anthracene. Int J Cancer 118:17–24
Park J, Zhao H, Chang S (2014) The unique mechanism of SNX9 BAR domain for inducing membrane tubulation. Mol Cells 37:753–758
Person MD, Shen J, Traner A, Hensley SC, Lo HH, Abbruzzese JL et al (2006) Protein fragment domains identified using 2D gel electrophoresis/MALDI-TOF. J Biomol Tech 17:145–156
Pfister SX, Ahrabi S, Zalmas LP, Sarkar S, Aymard F, Bachrati CZ et al (2014) SETD2-dependent histone H3K36 trimethylation is required for homologous recombination repair and genome stability. Cell Rep 7:2006–2018
Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE (1990) Increased cell division as a cause of human cancer. Cancer Res 50:7415–7421
Ruehl-Fehlert C, Kittel B, Morawietz G, Deslex P, Keenan C, Mahrt CR et al (2003) Revised guides for organ sampling and trimming in rats and mice—part 1. Exp Toxicol Pathol 55:91–106
Russo J, Russo IH (2000) Atlas and histologic classification of tumors of the rat mammary gland. J Mammary Gland Biol Neoplasia 5:187–200
Santisteban M, Reynolds C, Barr Fritcher EG, Frost MH, Vierkant RA, Anderson SS et al (2010) Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia. Breast Cancer Res Treat 121:431–437
Shaaban AM, Sloane JP, West CR, Foster CS (2002) Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-alpha and Ki-67 expression. Am J Pathol 160:597–604
Shin N, Ahn N, Chang-Ileto B, Park J, Takei K, Ahn SG et al (2008) SNX9 regulates tubular invagination of the plasma membrane through interaction with actin cytoskeleton and dynamin 2. J Cell Sci 121:1252–1263
Soverini S, De Benedittis C, Rondoni M, Mancini M, Papayannidis C, Guadagnuolo V et al (2014) Inactivation of the SETD2 tumor suppressor Gene in mast cell leukemia. Blood 124:1881
Tacha D, Zhou D, Cheng L (2011) Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study. Appl Immunohistochem Mol Morphol 19:293–299
Ting AY, Kimler BF, Fabian CJ, Petroff BK (2007) Characterization of a preclinical model of simultaneous breast and ovarian cancer progression. Carcinogenesis 28:130–135
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108
Wagner EJ, Carpenter PB (2012) Understanding the language of Lys36 methylation at histone H3. Nat Rev Mol Cell Biol 13:115–126
Wellings S, DeVault M, Jenfoft V, Richards J, Yang J, Nandi S et al (1981) Early lesions of the human mammary gland and their relationship to precancerous lesions of other species. New Frontiers in Mammary Pathology:27–50
Ye F, Tang H, Liu Q, **e X, Wu M, Liu X et al (2014) miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family. J Transl Med 12:17
Zhang R, Yang D, Zhou C, Cheng K, Liu Z, Chen L et al (2012) Beta-actin as a loading control for plasma-based western blot analysis of major depressive disorder patients. Anal Biochem 427:116–120
Acknowledgments
We are highly grateful to the University Grants Commission (UGC), India, for the financial support (F. No. 7-357/2011(BSR)) during this study. Further, the technical assistance provided by Dr. A K Tiwari (Veterinary Officer, Jamia Hamdard) and Dr. Prishla Varghese is also acknowledged.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Funding
This study was funded by the University Grants Commission, India (grant number 7-357/2011(BSR)).
Ethical approval
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures for using experimental animals were reviewed and approved (Approval ID/Project Number: 975) by the Institutional Animal Ethical Committee, accredited by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Government of India.
Additional information
Handling editor: Jan Raoul De Mey
Electronic supplementary material
Fig. S1
(GIF 86 kb)
Rights and permissions
About this article
Cite this article
Ganaie, I.A., Naqvi, S.H., Jain, S.K. et al. Reduced expression of SETD2 and SNX9 proteins in chemically induced mammary tumorigenesis in Wistar rats: a prognostic histological and proteomic study. Protoplasma 254, 1451–1466 (2017). https://doi.org/10.1007/s00709-016-1035-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00709-016-1035-2